ROCKWELL MEDICAL, INC. (RMTI) Operating margin 2017–2025
ROCKWELL MEDICAL, INC. (RMTI) operating margin by fiscal year — reported operating income divided by reported revenue.
-6.8%FY2025 · since FY2017: -45.2% → -6.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.8% | -7.4 pp |
| FY2024 | 0.6% | +8.6 pp |
| FY2023 | -8.0% | +15.1 pp |
| FY2022 | -23.0% | +25.9 pp |
| FY2021 | -49.0% | -3.3 pp |
| FY2020 | -45.7% | +10.6 pp |
| FY2019 | -56.3% | -5.1 pp |
| FY2018 | -51.2% | -5.9 pp |
| FY2017 | -45.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RMTI financial trends
RMTI RevenueRMTI Net incomeRMTI Net marginRMTI Gross profitRMTI Gross marginRMTI Operating incomeRMTI Operating cash flowRMTI Free cash flowRMTI Capital expendituresRMTI Return on equityRMTI Stock buybacksRMTI Dividends paidRMTI Total assetsRMTI Total liabilitiesRMTI Shareholders’ equityRMTI overview →